241 related articles for article (PubMed ID: 35257899)
1. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease.
Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R
Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899
[TBL] [Abstract][Full Text] [Related]
2. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
Lu Y; Tan L; Wang X
Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
[TBL] [Abstract][Full Text] [Related]
3. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
4. miR-30a-5p mediates ferroptosis of hippocampal neurons in chronic cerebral hypoperfusion-induced cognitive dysfunction by modulating the SIRT1/NRF2 pathway.
Wang L; Li M; Liu B; Zheng R; Zhang X; Yu S
Brain Res Bull; 2024 Jun; 212():110953. PubMed ID: 38636610
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a-5p Promotes Chronic Heart Failure in Rats by Targeting Sirtuin-1 to Activate the Nuclear Factor-κB/NOD-Like Receptor 3 Signaling Pathway.
Wu YX; Xu RY; Jiang L; Chen XY; Xiao XJ
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1065-1076. PubMed ID: 35488974
[TBL] [Abstract][Full Text] [Related]
6. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
Li Q; Li X; Wang L; Zhang Y; Chen L
J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β.
Lee HR; Shin HK; Park SY; Kim HY; Lee WS; Rhim BY; Hong KW; Kim CD
J Neurosci Res; 2014 Nov; 92(11):1581-90. PubMed ID: 24903973
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
9. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice.
Fu CH; Han XY; Tong L; Nie PY; Hu YD; Ji LL
Behav Brain Res; 2021 Sep; 414():113485. PubMed ID: 34302879
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
12. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.
Wan W; Liu G; Li X; Liu Y; Wang Y; Pan H; Hu J
Bioengineered; 2021 Dec; 12(2):12678-12690. PubMed ID: 34818971
[TBL] [Abstract][Full Text] [Related]
13. Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers.
Wang R; Chopra N; Nho K; Maloney B; Obukhov AG; Nelson PT; Counts SE; Lahiri DK
Mol Psychiatry; 2022 Feb; 27(2):1256-1273. PubMed ID: 35087196
[TBL] [Abstract][Full Text] [Related]
14. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models.
Zhang Z; Shen Q; Wu X; Zhang D; Xing D
Aging Cell; 2020 Jan; 19(1):e13054. PubMed ID: 31663252
[TBL] [Abstract][Full Text] [Related]
15. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
16. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
17. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.
Donmez G; Wang D; Cohen DE; Guarente L
Cell; 2010 Jul; 142(2):320-32. PubMed ID: 20655472
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice.
Kwon H; Lee EH; Park SY; Park JY; Hong JH; Kim EK; Shin TS; Kim YK; Han PL
Exp Mol Med; 2023 Sep; 55(9):2067-2082. PubMed ID: 37704750
[TBL] [Abstract][Full Text] [Related]
20. Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Lee K; Kim H; An K; Kwon OB; Park S; Cha JH; Kim MH; Lee Y; Kim JH; Cho K; Kim HS
Sci Rep; 2016 Oct; 6():34433. PubMed ID: 27708404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
